I am a
Home I AM A Search Login

Papers of the Week

2020 Jun

J Eur Acad Dermatol Venereol



Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasis.


Merola JF, Ghislain P-D, Dauendorffer JN, Potts Bleakman A, Brnabic AJM, Burge R, Riedl E
J Eur Acad Dermatol Venereol. 2020 Jun; 34(6):1257-1262.
PMID: 31919919.


Epithelial surface disruption in genital psoriatic lesions may manifest as erosions, fissures and/or ulcers, causing pain and significantly impacting a patient's sexual health.